Portage Biotech Inc. Files March 2024 6-K Report
Ticker: ATON · Form: 6-K · Filed: Mar 7, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-issuer
TL;DR
Portage Biotech Inc. filed its monthly 6-K report, standard procedure for foreign issuers.
AI Summary
Portage Biotech Inc. filed a Form 6-K on March 7, 2024, reporting for the month of March 2024. The company, incorporated in the British Virgin Islands, has its principal executive offices in Tortola. The filing is related to its status as a foreign private issuer under the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Portage Biotech Inc.'s ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine operational report and does not contain significant new financial or strategic information that would immediately impact risk.
Key Numbers
- 001-40086 — SEC File Number (Identifies the company's filing history with the SEC)
- 20240307 — Filing Date (Date the report was officially filed with the SEC)
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the report
- British Virgin Islands (jurisdiction) — Jurisdiction of incorporation
- Ian Walters (person) — Company contact person
- 203.221.7378 (phone_number) — Contact phone number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the issuer makes or is required to make public in its home country.
Where is Portage Biotech Inc. incorporated?
Portage Biotech Inc. is incorporated in the British Virgin Islands.
What is the company's principal executive office address?
The principal executive offices are located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Who is the designated contact person for this filing?
The designated contact person is Ian Walters, with a phone number of 203.221.7378.
What is the SEC file number for Portage Biotech Inc.?
The SEC file number for Portage Biotech Inc. is 001-40086.
Filing Stats: 274 words · 1 min read · ~1 pages · Grade level 11.6 · Accepted 2024-03-06 21:11:09
Filing Documents
- f6k_030624.htm (6-K) — 14KB
- exh_991.htm (EX-99.1) — 26KB
- exh991_01.jpg (GRAPHIC) — 102KB
- exh991_02.jpg (GRAPHIC) — 296KB
- exh991_03.jpg (GRAPHIC) — 200KB
- exh991_04.jpg (GRAPHIC) — 198KB
- exh991_05.jpg (GRAPHIC) — 138KB
- exh991_06.jpg (GRAPHIC) — 132KB
- exh991_07.jpg (GRAPHIC) — 206KB
- exh991_08.jpg (GRAPHIC) — 127KB
- exh991_09.jpg (GRAPHIC) — 125KB
- exh991_10.jpg (GRAPHIC) — 166KB
- exh991_11.jpg (GRAPHIC) — 131KB
- exh991_12.jpg (GRAPHIC) — 132KB
- exh991_13.jpg (GRAPHIC) — 168KB
- exh991_14.jpg (GRAPHIC) — 118KB
- exh991_15.jpg (GRAPHIC) — 147KB
- exh991_16.jpg (GRAPHIC) — 117KB
- exh991_17.jpg (GRAPHIC) — 183KB
- 0001171843-24-001217.txt ( ) — 3742KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40086 Portage Biotech Inc. (Translation of registrant’s name into English) N/A (Translation of registrant’s name into English) British Virgin Islands (Jurisdiction of incorporation or organization) Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 (Address of principal executive offices) c/o Portage Development Services Inc., Ian Walters, 203.221.7378 61 Wilton Road, Westport, Connecticut 06880 (Name, telephone, e-mail and/or facsimile number and Address of Company Contact Person) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F INCORPORATION BY REFERENCE This report on Form 6-K (including the exhibits attached hereto) shall be deemed to be incorporated by reference into the registration a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Exhibits The following Exhibit is filed with this report: Exhibit Description 99.1 Corporate Presentation SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Portage Biotech, Inc. Date: March 7, 2024 By: /s/ Allan Shaw Name: Allan Shaw Title: Chief Financial Officer